Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates

Journal of Medicinal Chemistry

Volumn 55, Issue 6, 2012, Pages 2835-2845

  Hen, Naama ^a   Bialer, Meir ^a,b   Yagen, Boris ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 3 METHYL BUTYL CARBAMATE; 2 ETHYL 3 METHYL PENTYL CARBAMATE; 2 ETHYL 4 METHYL PENTYL CARBAMATE; 2 ETHYL BUTYL CARBAMATE; 2 ETHYL HEXYL CARBAMATE; 2 ISOPROPYL 3 METHYL BUTYL CARBAMATE; 2 ISOPROPYL 3 METHYL PENTYL CARBAMATE; 2 ISOPROPYL PENTYL CARBAMATE; 2 METHYL 4,4 DIMETHYL PENTYL CARBAMATE; 2 PROPYL 3 METHYL PENTYL CARBAMATE; 2 PROPYL PENTYL CARBAMATE; 2,2 DIMETHYL PROPYL CARBAMATE; 2,2,3,3 TETRAMETHYLCYCLOPROPYLMETHYLEN CARBAMATE; 2,3 DIMETHYL BUTYL CARBAMATE; 3 METHYL PENTYL CARBAMATE; 3,3 DIMETHYL BUTYL CARBAMATE; ANTICONVULSIVE AGENT; N CYCLOHEXYL 2 PROPYL PENTYL CARBAMATE; N METHYL 2 PROPYL PENTYL CARBAMATE; PENTETRAZOLE; PHENYL ETHYL CARBAMATE; PHENYLETHYL CARBAMATE; PILOCARPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; DRUG SYNTHESIS; ELECTRIC SHOCK; EPILEPTIC STATE; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALS; ANTICONVULSANTS; CARBAMATES; MALE; MICE; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; STATUS EPILEPTICUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84858713945     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201751x     Document Type: Article

References (47)

1. White, H. S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs Epilepsia 1999, 40 (Suppl. 5) S2-S10 (Pubitemid 29484583)
2. Madsen, K. K.; Clausen, R. P.; Larsson, O. M.; Krogsgaard-Larsen, P.; Schousboe, A.; White, H. S. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs J. Neurochem. 2009, 109 (Suppl. 1) 139-144
3. Perucca, E.; French, J.; Bialer, M. Development of new antiepileptic drugs: Challenges, incentives, and recent advances Lancet Neurol. 2007, 6, 793-804 (Pubitemid 47243712)
4. Smith, M.; Wilcox, K. S.; White, H. S. Discovery of antiepileptic drugs Neurotherapeutics 2007, 4, 12-17 (Pubitemid 46107328)
5. Loiseau, P. Do we need novel anti-epileptic drugs? Br. J. Clin. Prac. 1988, 42, 2-3
6. Schmidt, D. Anticonvulsant. In Meyler's Side Effect of Drugs, 12 th ed.; Duke, M. N. G., Ed.; Elsevier: Amsterdam, 1992; pp 122-143.
7. Bialer, M.; Johannessen, S. I.; Levy, R. H.; Perucca, E.; Tomson, T.; White, H. S. Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X) Epilepsy Res. 2010, 92, 89-124
8. Bialer, M.; Yagen, B. Valproic acid: second generation Neurotherapeutics 2007, 4, 130-137 (Pubitemid 46107326)
9. Nau, H.; Loscher, W. Pharmacologic evaluation of various metabolites and analogs of valproic acid: Teratogenic potencies in mice Fundam. Appl. Toxicol. 1986, 6, 669-676 (Pubitemid 16110138)
10. Ludwig, B. J.; Piech, E. C. Some anticonvulsant agents derived from 1,3-propandiol J. Am. Chem. Soc. 1951, 73, 5779-5781
11. Ludwig, B. J.; Powell, E. C.; Berger, F. M. Carbamate derivatives related to meprobamate J. Med. Chem. 1968, 12, 462-474
12. Close, W. J.; Spielman, M. A. Anticonvulsant drugs. In Medicinal Chemistry Hartung, W. H., Ed.; John Wiley and Sons: New York, 1961; Vol. 5, Issue 1-47, pp 143-150.
13. Daleva, L.; Nikolova, M. On the pharmacology of certain esters of the carbamic acid Farmatsiya (Moscow) 1964, 14, 13-17
14. Nikolova, M. On the pharmacology of certain esters of the carbamic acid. III communication Farmatsiya (Moscow) 1965, 15, 32-39
15. Taillandier, G.; Benoit-Guyod, J. L.; Boucherle, A.; Broll, M.; Eymard, P. Recherches dans la serie dipropylacetique XII. Acides et alcohols aliphatiques ramifies anticonvulsivants Eur. J. Med. Chem. 1975, 5, 453-462
16. Yamagami, C.; Sonoda, C.; Takao, N.; Tanaka, M.; Yamada, J.; Horisaka, K.; Fujita., T. A quantitative structure-activity study of anticonvulsant benzyl N,N -dimethylcarbamate Chem. Pharm. Bull. 1982, 30, 4175-4180 (Pubitemid 13177258)
17. Yamagami, C.; Takao, N.; Tanaka, M.; Horisaka, K.; Asada, S.; Fujita, T. A quantitative structure-activity study of anticonvulsant phenylacetanilides Chem. Pharm. Bull. 1984, 32, 5003-5009 (Pubitemid 15151726)
18. Tanaka, M.; Horisaka, K.; Yamagami, C.; Takao, N.; Fujita, T. Quantitative structure-activity relationship of anticonvulsant arylalkyl and alkyl carbamates Chem. Pharm. Bull. 1985, 33, 2403-2410 (Pubitemid 15073783)
19. Frey, H. H.; Bartels, I. Felbamate and meprobamate: A comparison of their anticonvulsant properties Epilepsy Res. 1997, 27, 151-164 (Pubitemid 27306797)
20. Jensen, P. K. Felbamate in the treatment of refractory partial-onset seizures Epilepsia 1993, 34 (Suppl. 7) S25-S29 (Pubitemid 24000781)
21. Pellock, J. M.; Perhach, J. L.; Sofia, R. D. Felbamate. In Antiepileptic Drugs, 5 th ed.; Levy, R. H.; Mattson, R. H.; Meldrum, B. S.; Perucca, E., Eds.; Lippincott Williams & Wilkins Publishers: New York, 2002; pp 301-320.
22. Bialer, M.; Johannessen, S. I.; Levy, R. H.; Perucca, E.; Tomson, T.; White, H. S. Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX) Epilepsy Res. 2009, 83, 1-43
23. Kung, C. H.; Kwon, C. H. Carbamate derivatives of felbamate as potential anticonvulsant agents Med. Chem. Res. 2010, 19, 498-513
24. Shimshoni, J. A.; Bialer, M.; Wlodarczyk, B.; Finnell, R. H.; Yagen, B. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid J. Med. Chem. 2007, 50, 6419-6427 (Pubitemid 350250429)
25. Pfeffer, P. E.; Silbert, L. S.; Chirinko, J. M. Alpha-anions of carboxylic acids. II. The formation and alkylation of alpha-methylated aliphatic acids J. Org. Chem. 1972, 37, 451-458
26. Furniss, B. S.; Hannaford, A. J.; Smith, P. W. G.; Tatchell, A. R. Vogel's Textbook of Practical Organic Chemistry; Prentice Hall: New York, 1989; pp 446-447.
27. Rogawski, M. A.; Loscher, W. The neurobiology of antiepileptic drugs Nature Rev. Neurosci. 2004, 5, 553-564 (Pubitemid 38868551)
28. Bialer, M.; White, H. S. Key factors in the discovery and development of new antiepileptic drugs (AEDs) Nature Rev. Drug Discovery 2010, 9, 68-83
29. Tomson, T.; Battino, D.; Bonizzoni, E.; Carig, J.; Lindhout, D.; D Sabers, A.; Perucca, E.; Vajda, F. for the EURAP group. Dose-dependent risk of malformations with antiepileptic drugs: An analysis of data from the EURAP epilepsy and pregnancy registry Lancet Neurol. 2011, 10, 609-617
30. Molgaard-Nielsen, D.; Hviid, A. Newer generation antiepileptic drugs and the risk of major birth defects J. Am. Med. Assoc. 2011, 305, 1996-2002
31. Vajda, J. E.; Graham, J.; Roten, A; Lander, C. M.; O'Brien, T. J.; Eadie, M. Teratogenicity of the newer antiepileptic drugs -the Australian experience J. Clin. Neurosci. 2012, 19, 57-59
32. Meador, K. J. Effects of in utero antiepileptic drug exposure Epilepsy Curr. 2008, 6, 143-147
33. Perucca, E. The pharmacology of new antiepileptic drugs. Does novel mechanism of action really matter? CNS Drugs 2011, 25, 907-912
34. Schmidt, D. Antiepileptic drug discovery; Does mechanism of action matter? Epilepsy Behav. 2011, 21, 342-343
35. Bialer, M. New antiepileptic drugs that are second generation to existing antiepileptic drugs Expert Opin. Invest. Drugs 2006, 15, 637-647
36. White, H. S.; Woodhead, J. H.; Wilcox, K. S.; Stables, J. P.; Kupferberg, H. J.; Wolf, H. H. Discovery and Preclinical Development of Antiepileptic Drugs, 5 th ed.; Lippincott Williams & Wilkins: New York, 2002; pp 36-48.
37. Schmidt, D.; Rogawski, M. A. New strategies for the identification of drugs to prevent the development or progression of epilepsy Epilepsy Res. 2002, 50, 71-78 (Pubitemid 34876588)
38. Margineanu, D. G. Systems biology impact of antiepileptic drug discovery Epilepsy Res. 2011, 50, 71-78
39. Loscher, W. Valproic acid mechanism of action. In Antiepileptic Drugs, 5 th ed.; Levy, R. H.; Mattson, R. H.; Meldrum, B. S.; Perucca, E., Eds.; Lippincott Williams & Wilkins Publishers: New York, 2002; pp 767-779.
40. Nalivaeva, N. N.; Belyaev, N. C. D.; Turner, A. J. Sodium valproate: An old drug with new roles THIPS 2009, 30, 509-514
41. White, H. S.; Alex, A. B.; Pollock, A.; Hen, N.; Shekh-Ahmed, T.; Wilcox, K. S.; McDonough, J. H.; Stables, J. P.; Kaufmann, D.; Yagen, B.; Bialer, B. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage Epilepsia 2012, 53, 134-146
42. Racine, R. Modification of seizure activity by electrical stimulation. 2. Motor Seizures Electroencephalogr. Clin. Neurophysiol. 1972, 32, 281-294
43. Palaty, J.; Abbott, F. S. Structure-activity relationships of unsaturated analogues of valproic acid J. Med. Chem. 1995, 38, 3398-3406
44. Elmazar, M. M.; Hauck, R. S.; Nau, H. Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid J. Pharm. Sci. 1993, 82, 1255-1258
45. Abbott, F. S.; Acheampong, A. A. Quantitative structure-anticonvulsant activity relationships of valproic acid, related carboxylic acids and tetrazoles Neuropharmacology 1988, 27, 287-294 (Pubitemid 18080961)
46. Marchi, N.; Betto, G.; Fazio, V.; Fan, Q.; Ghosh, C.; Machado, A.; Janigro, D. Blood-brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edema Epilepsia 2009, 50, 664-677
47. Emma, S. J.; Williams, M. Challenges in the search for drugs to treat central nerve system disorders J. Pharamcol. Exp. Ther. 2009, 329, 401-411